Volume 18 Issue 3, March 2016

Newborn testing and screening by whole-genome sequencing

• Stephen F. Kingsmore

Should states adopt newborn screening for early infantile Krabbe disease?

• David P. Dimmock

Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates

• Dale L. Bodian
• Elisabeth Klein
• Benjamin D. Solomon

Improving newborn screening for cystic fibrosis using next-generation sequencing technology: a technical feasibility study

• Mei W. Baker
• Anne E. Atkins
• Philip M. Farrell

Newborn screening for Krabbe disease in New York State: the first eight years’ experience

• Joseph J. Orsini
• Denise M. Kay
• Michele Caggana

Parents’ experiences 12 years after newborn screening for genetic susceptibility to type 1 diabetes and their attitudes to whole-genome sequencing in newborns

• Nicola Kerruish

Damaged goods?: an empirical cohort study of blood specimens collected 12 to 23 hours after birth in newborn screening in California

• Hao Tang
• Lisa Feuchtbaum
• Robert J. Currier

Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium

• Frédéric B. Piel
• Thomas V. Adamkiewicz
• Scott D. Grosse

Expanding noninvasive prenatal testing to include microdeletions and segmental aneuploidy: cause for concern?

• Trilochan Sahoo
• Karine Hovanes
• Mary K. Travis

Response to Sahoo et al.

• Svetlana A. Yatsenko
• David G. Peters
• Aleksandar Rajkovic

Announcement

Erratum: Observed and expected frequencies of structural hemoglobin variants in newborn screening surveys in Africa and the Middle East: deviations from Hardy-Weinberg equilibrium

• Frédéric B. Piel
• Thomas V. Adamkiewicz
• Scott D. Grosse